SYMPHONY-PE Study for Treatment of Pulmonary Embolism
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT06062329
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 110 participants
- Sponsor
- Imperative Care, Inc.
- Registry
-
NCT06062329
-
- Other papers using this trial's data
- Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06062329. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-13 (actual); primary completion 2025-05-04 (actual). Results posted on 2026-08-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SYMPHONY-PE Study for Treatment of Pulmonary Embolism
- Condition
- Acute Pulmonary Embolism
- Condition
- Thromboembolism
- Condition
- Emboli, Pulmonary
- Condition
- Thrombosis
- Condition
- Thrombus; Embolism
- Condition
- Embolism
- Condition
- Cardiovascular Diseases
- Condition
- Vascular Diseases
- Intervention (Device)
- Symphony Thrombectomy System
- Lead sponsor
- Imperative Care, Inc.
Record details
- Record id
cardio:ct-nct06062329- Content hash
6500694cfd8d6819260de76bcd0a7cfaeddb16641cc632af95164fcc908031e3